Ebitda, as per the poll, is seen at Rs 768 crore compared with Rs 363 crore, up 112 per cent YoY. Ebitda margin is seen rising to 23.1 per cent from 18.4 per cent YoY. All eyes would be on raw material cost inflation, the company’s plans to expand in new geographies and the outlook on VECV vehicles.
West Asia tensions rattle Dalal Street; pharma and metals buck the trend
West Asian conflict’s spillover to India fueled investor uncertainty, impacting sectoral indices except pharmaceuticals and metals. Export-facing sectors and those reliant on crude oil and